how long have people been using semaglutide Beyond Semaglutide: The Next-Generation Weight Loss Drugs That Could Change Everything In 2026 Have you been prescribed GLP-1

We therefore set out to examine whether treatment with GLP-1 receptor agonists is associated with a different incidence of rheumatic diseases compared to DPP-4 inhibitors, another common class of diabetes medications. To that end, Ibis and colleagues conducted a propensity score-matched cohort study using data from the TriNetX Analytics Network

Once you've taken the quiz, one of our GPhC-registered prescribers will review your answers

Where it's most often discussed: Tissue repair and recovery models (especially tendons/ligaments and muscle) Wound healing and regenerative signaling Gut integrity and inflammation-related pathways Where it's not firmly established: Extensive, rigorous human studies designed to measure fat loss outcomes (fat mass, waist circumference, body fat percentage) That distinction matters

D.Sannappa GowdaN